Subscribe to Florida Trend

NAVIGATION

September 25, 2018

Miami-Dade Business Profile

Biscayne Pharmaceuticals

| 8/14/2013
Samuel Reich and Andrew Schally (sitting)
Samuel Reich (standing) and Andrew Schally

For more than half a century, Nobel Prize-winning scientist and University of Miami faculty member Andrew Schally has been researching the hormones that stimulate growth in the body’s tissues. Now his work is being used by Miami-based Biscayne Pharmaceuticals, which was founded last year and licensed from UM the rights to Schally’s inventions related to that research. The company, which Schally works with as scientific adviser, is using his discovery to develop possible treatments for cancer and heart disease.

Biscayne Pharma got going after a $1.5-million investment from its co-founders and Miami Beach investment firm Reich Group, whose Managing Partner Samuel Reich joined Biscayne Pharma as CEO. “This is a breakthrough that will really transform the way we treat cancer,” Reich says.

Tags: Miami-Dade, Healthcare, Technology/Innovation

Digital Access

DIRECT DIGITAL ACCESS
Add digital to your current subscription, purchase a single digital issue, or start a new subscription to Florida Trend.

TABLE OF CONTENTS
An overview of the features and articles in this month's issue of Florida Trend.

ACCESS THIS ISSUE »

Florida Business News

Florida Trend Video Pick

Massive ‘Innovation District’ could change Little Haiti forever. But what would that mean?
Massive ‘Innovation District’ could change Little Haiti forever. But what would that mean?

The Magic City Innovation District, a $1 billion real estate development will bring residential, commercial, retail and entertainment spaces to Miami’s Little Haiti neighborhood. Residents fear gentrification.

Earlier Videos | Viewpoints@FloridaTrend

Ballot Box

How do you prefer to listen to recorded music?

  • Local radio
  • Streaming services
  • CDs
  • Records
  • I dont' listen to music much
  • Other (comments welcome)

See Results

Ballot Box
Subscribe